US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ping An Biomedical Co., Ltd.

0.2320

+0.01356.18%

Post-market: 0.1849-0.0471-20.30%18:58 EST

Volume:6.24M

Turnover:1.55M

Market Cap:5.70M

PE:-2.38

High:0.2713

Open:0.2290

Low:0.2232

Close:0.2185

52wk High:5.40

52wk Low:0.1607

Shares:24.55M

Float Shares:9.69M

Volume Ratio:2.80

T/O Rate:64.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0975

EPS(LYR):-0.0975

ROE:-67.43%

ROA:-14.67%

PB:0.87

PE(LYR):-2.38

Loading ...

Overview Company News Filings

Ping an Biomedical Co Ltd - to Resale up to 13.6 Mln Ordinary Shares by Selling Shareholder - SEC Filing

THOMSON REUTERS

Ping An Biomedical Co. files to sell 13.61M ordinary shares for holders

Ping an Biomedical Co Ltd: Entered Into Securities Purchase Agreements, Agreed to Issue & Sell, in Private Placement 100 Mln Ordinary Shares

THOMSON REUTERS

Ping An Biomedical Raises $4 Million in Private Share Placement

Ping An Biomedical FY2025 revenue drops 61% to CNY 34.1 million

PASW.US Plummets 97% in Six Months Since IPO; Can a Name Change Reverse the Downtrend?

BRIEF-Ping An Biomedical Co., Ltd Announces Strategic Investment In Future Biotechnology Group

Ping an: Investment Memorandum Outlines Initial Investment of US$30 Mln to Be Paid in Cash

THOMSON REUTERS

Ping an Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry

THOMSON REUTERS

Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation

Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter

Majestic Ideal Holdings Ltd. Announces New Chairman, CEO, CFO, and Independent Director in Leadership Reshuffle

Majestic Ideal Holdings Ltd. Reports First Half 2025 Net Loss of RMB 0.01 Per Share

Majestic Ideal Holdings Ltd Rebrands to Ping An Biomedical Co., Ltd.

Majestic Ideal Holdings: to Change Name to Ping an Biomedical Co Ltd - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PASW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PASW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PASW\",,,,,undefined,":{"symbol":"PASW","market":"US","secType":"STK","nameCN":"Ping An Biomedical Co., Ltd.","latestPrice":0.232,"timestamp":1771016400000,"preClose":0.2185,"halted":0,"volume":6242630,"hourTrading":{"tag":"盘后","latestPrice":0.1849,"preClose":0.232,"latestTime":"18:58 EST","volume":843662,"amount":152178.00517966,"timestamp":1771027116332,"change":-0.0471,"changeRate":-0.203017,"amplitude":0.464655},"delay":0,"changeRate":0.06178489702517168,"floatShares":9688200,"shares":24550000,"eps":-0.097517,"marketStatus":"Post-Mkt","change":0.0135,"latestTime":"02-13 19:00:26 EST","open":0.229,"high":0.2713,"low":0.2232,"amount":1551029.8663088,"amplitude":0.220137,"askPrice":0.2007,"askSize":100,"bidPrice":0.1849,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-0.097517,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771030800000},"marketStatusCode":4,"adr":0,"listingDate":1752811200000,"exchange":"NASDAQ","adjPreClose":0.2185,"preHourTrading":{"tag":"盘前","latestPrice":0.2345,"preClose":0.2185,"latestTime":"09:27 EST","volume":152806,"amount":36014.70708654,"timestamp":1770992851239,"change":0.016,"changeRate":0.073227,"amplitude":0.09611},"postHourTrading":{"tag":"盘后","latestPrice":0.1849,"preClose":0.232,"latestTime":"18:58 EST","volume":843662,"amount":152178.00517966,"timestamp":1771027116332,"change":-0.0471,"changeRate":-0.203017,"amplitude":0.464655},"volumeRatio":2.795322},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PASW\",,,,,undefined,":{"symbol":"PASW","floatShares":9688200,"roa":"-14.67%","roe":"-67.43%","lyrEps":-0.097517,"volumeRatio":2.795322,"shares":24550000,"dividePrice":0,"high":0.2713,"amplitude":0.220137,"preClose":0.2185,"low":0.2232,"week52Low":0.1607,"pbRate":"0.87","psRate":"1.15","week52High":5.4,"institutionHeld":0,"latestPrice":0.232,"committee":-0.960784,"eps":-0.097517,"divideRate":0,"volume":6242630,"delay":0,"ttmEps":-0.097517,"open":0.229,"prevYearClose":0.5015,"prevWeekClose":0.2201,"prevMonthClose":0.228,"prevQuarterClose":0.5015,"fiveDayClose":0.2201,"twentyDayClose":0.2175,"sixtyDayClose":0.5647},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PASW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PASW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PASW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PASW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PASW","date":"2026-02-12","current":-2.375996,"percent":0.934066,"low":-27.642982,"twenty":-18.958288,"median":-14.434604,"eighty":-5.644968,"high":-2.158447,"avg":-13.495669,"sd":6.47073,"marketCap":4932300},"quantilePoints":[{"date":"2025-10-03","current":-27.642982,"twenty":-27.100774,"median":-26.287462,"eighty":-25.474149,"marketCap":22345000},{"date":"2025-10-10","current":-25.389744,"twenty":-26.17821,"median":-25.146005,"eighty":-24.967093,"marketCap":20500000},{"date":"2025-10-17","current":-19.290895,"twenty":-25.340996,"median":-24.517706,"eighty":-21.88626,"marketCap":15582050},{"date":"2025-10-24","current":-18.108958,"twenty":-25.138344,"median":-23.076466,"eighty":-19.303276,"marketCap":14632900},{"date":"2025-10-31","current":-19.067929,"twenty":-25.07255,"median":-19.526371,"eighty":-18.995656,"marketCap":15434450},{"date":"2025-11-07","current":-15.165603,"twenty":-24.766247,"median":-19.290895,"eighty":-18.473632,"marketCap":12259000},{"date":"2025-11-14","current":-15.666895,"twenty":-23.967786,"median":-19.046503,"eighty":-16.622066,"marketCap":12707950},{"date":"2025-11-21","current":-14.436215,"twenty":-23.35533,"median":-18.993416,"eighty":-15.508565,"marketCap":11685000},{"date":"2025-11-28","current":-11.52221,"twenty":-23.076466,"median":-18.775446,"eighty":-14.886858,"marketCap":9364400},{"date":"2025-12-05","current":-12.456059,"twenty":-21.588709,"median":-17.944403,"eighty":-13.956973,"marketCap":10137250},{"date":"2025-12-12","current":-14.54413,"twenty":-19.637491,"median":-16.473929,"eighty":-13.460785,"marketCap":11859250},{"date":"2025-12-19","current":-14.520813,"twenty":-19.415251,"median":-15.69775,"eighty":-13.503287,"marketCap":11869500},{"date":"2025-12-26","current":-15.98453,"twenty":-19.365289,"median":-15.856568,"eighty":-13.636869,"marketCap":13120000},{"date":"2026-01-02","current":-12.492509,"twenty":-19.315657,"median":-15.69775,"eighty":-13.438677,"marketCap":10280750},{"date":"2026-01-09","current":-15.381107,"twenty":-19.166951,"median":-15.393631,"eighty":-12.801755,"marketCap":12675150},{"date":"2026-01-16","current":-5.396992,"twenty":-19.074486,"median":-15.205247,"eighty":-12.608022,"marketCap":4458750},{"date":"2026-01-23","current":-4.480642,"twenty":-19.050788,"median":-14.977877,"eighty":-12.470639,"marketCap":3698200},{"date":"2026-01-30","current":-5.887937,"twenty":-19.016893,"median":-14.673796,"eighty":-11.613586,"marketCap":4876950},{"date":"2026-02-06","current":-2.158447,"twenty":-19.000136,"median":-14.532471,"eighty":-6.397256,"marketCap":3991350},{"date":"2026-02-12","current":-2.65319,"twenty":-18.958288,"median":-14.434604,"eighty":-5.644968,"marketCap":4932300}],"updateTime":1770993399826},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PASW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611956641","title":"Ping an Biomedical Co Ltd - to Resale up to 13.6 Mln Ordinary Shares by Selling Shareholder  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611956641","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611956641?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:55","pubTimestamp":1771019722,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z91DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4159","PASW"],"gpt_icon":0},{"id":"2611195948","title":"Ping An Biomedical Co. files to sell 13.61M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195948","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195948?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:55","pubTimestamp":1771019712,"startTime":"0","endTime":"0","summary":"16:53 EST Ping An Biomedical Co. (PASW) files to sell 13.61M ordinary shares for holders Published first on TheFly – the ultimate source for real-t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ping-an-biomedical-co-files-to-sell-13-61m-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ping-an-biomedical-co-files-to-sell-13-61m-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4159","PASW","PAImain"],"gpt_icon":0},{"id":"2611903877","title":"Ping an Biomedical Co Ltd: Entered Into Securities Purchase Agreements, Agreed to Issue & Sell, in Private Placement 100 Mln Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2611903877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611903877?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:46","pubTimestamp":1770932791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z81DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4159","PASW"],"gpt_icon":0},{"id":"2611908936","title":"Ping An Biomedical Raises $4 Million in Private Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2611908936","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611908936?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:32","pubTimestamp":1770931927,"startTime":"0","endTime":"0","summary":"Ping An Biomedical Co. Ltd. has entered into securities purchase agreements with certain accredited investors for a private placement of 100 million ordinary shares at $0.04 per share, raising a total of $4 million. The transaction, exempt from registration under the Securities Act of 1933, is expected to close within three business days, pending the satisfaction or waiver of customary closing conditions. The shares will be subject to transfer restrictions and have not been registered for public sale in the United States.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system opera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDLbwrPRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"gpt_icon":0},{"id":"2607025080","title":"Ping An Biomedical FY2025 revenue drops 61% to CNY 34.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025080","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607025080?lang=en_us&edition=fundamental","pubTime":"2026-01-31 03:12","pubTimestamp":1769800367,"startTime":"0","endTime":"0","summary":"Ping An Biomedical Co. Ltd. reported its financial results for the fiscal year ended September 30, 2025. The company posted total revenue of CNY 34.1 million  for the period. Sales of yarns amounted to CNY 32.4 million , while sales of finished garments totaled CNY 1.7 million . The company recorded a revenue decrease of 61.0 percent for the year ended September 30, 2025. Cost of revenue was CNY 33.2 million , with costs of yarns at CNY 31.8 million  and costs of finished garments at CNY 1.4 million .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL4t3J5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"gpt_icon":0},{"id":"1113673542","title":"PASW.US Plummets 97% in Six Months Since IPO; Can a Name Change Reverse the Downtrend?","url":"https://stock-news.laohu8.com/highlight/detail?id=1113673542","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113673542?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:59","pubTimestamp":1768485565,"startTime":"0","endTime":"0","summary":"In 2025, despite a complex and volatile external environment, 93 Chinese companies successfully listed on the main U.S. stock boards through IPOs, SPAC mergers, and OTC uplistings, marking a 7.8%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","PASW"],"gpt_icon":0},{"id":"2602937415","title":"BRIEF-Ping An Biomedical Co., Ltd Announces Strategic Investment In Future Biotechnology Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2602937415","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602937415?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:39","pubTimestamp":1767969558,"startTime":"0","endTime":"0","summary":"BRIEF-Ping An Biomedical Co., Ltd Announces Strategic Investment In Future Biotechnology Group Jan 9 (Reuters) - Ping An Biomedical Co Ltd PASW.O:PING AN BIOMEDICAL CO., LTD ANNOUNCES STRATEGIC INVEST","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA1MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"gpt_icon":1},{"id":"2602748013","title":"Ping an: Investment Memorandum Outlines Initial Investment of US$30 Mln to Be Paid in Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2602748013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602748013?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:25","pubTimestamp":1767968708,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA1MD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4159","PASW"],"gpt_icon":0},{"id":"2602374809","title":"Ping an Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2602374809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602374809?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:25","pubTimestamp":1767968708,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA1MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4159","PASW"],"gpt_icon":0},{"id":"2602373432","title":"Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2602373432","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602373432?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:05","pubTimestamp":1767960300,"startTime":"0","endTime":"0","summary":"HONG KONG, Jan.  09, 2026  (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) today announced that it has entered into a series of share purchas","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/09/3216021/0/en/Ping-An-Biomedical-Co-Ltd-Receives-Strategic-Investment-from-Leading-Industry-Capital-Accelerating-Growth-in-Biopharmaceutical-Innovation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW"],"gpt_icon":0},{"id":"2586862187","title":"Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2586862187","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586862187?lang=en_us&edition=fundamental","pubTime":"2025-11-28 19:00","pubTimestamp":1764327600,"startTime":"0","endTime":"0","summary":"Hong Kong, Nov.  28, 2025  (GLOBE NEWSWIRE) --  Ping An Biomedical Co., Ltd. (Nasdaq: PASW) (the “Company”) today announced receipt of Nasdaq Minimum Bid Price Deficiency Letter. On November 24, 2025,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/28/3196143/0/en/Ping-An-Biomedical-Co-Ltd-Announces-Receipt-of-Nasdaq-Minimum-Bid-Price-Deficiency-Letter.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","USAW.SI","MNQmain","USJW.SI","PSQ","QLD","TQQQ",".IXIC","NQmain","QID","PASW","SQQQ","TSYW.SI","BK4159"],"gpt_icon":1},{"id":"2575295666","title":"Majestic Ideal Holdings Ltd. Announces New Chairman, CEO, CFO, and Independent Director in Leadership Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2575295666","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575295666?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:04","pubTimestamp":1760436276,"startTime":"0","endTime":"0","summary":"Majestic Ideal Holdings Ltd. has announced significant management changes. Ms. Yuk Yin Judy Li, Ms. Lina Jiang, Ms. Xueyuan Chen, and Mr. Taylor Carl Coplen have resigned from their positions on the Board and executive team for personal reasons. The Board has appointed Mr. Pijun Liu as Chairman, Chief Executive Officer, and Executive Director, Ms. Hongli Yang as Chief Financial Officer, and Mr. Xianzhi Liu as Independent Director, effective October 14, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Majestic Ideal Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL5Ts0mY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","PASW"],"gpt_icon":0},{"id":"2571335701","title":"Majestic Ideal Holdings Ltd. Reports First Half 2025 Net Loss of RMB 0.01 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2571335701","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571335701?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:03","pubTimestamp":1759176201,"startTime":"0","endTime":"0","summary":"Majestic Ideal Holdings Ltd. released its unaudited financial results for the six months ended March 31, 2025. The company reported a net loss for the period, compared to a net loss in the same period of the previous year. The basic and diluted earnings per share were negative for both periods. The number of weighted average ordinary shares outstanding remained at 18 million for both the current and prior year periods. No significant updates regarding business operations or changes in business segments were disclosed in the financial statements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Majestic Ideal Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL2mPWFn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159","MJID"],"gpt_icon":0},{"id":"2570007936","title":"Majestic Ideal Holdings Ltd Rebrands to Ping An Biomedical Co., Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2570007936","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570007936?lang=en_us&edition=fundamental","pubTime":"2025-09-26 18:50","pubTimestamp":1758883823,"startTime":"0","endTime":"0","summary":"Majestic Ideal Holdings Ltd ( ($MJID) ) just unveiled an update. On September 12, 2025, the shareholders of Majestic Ideal Holdings Ltd approved a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/majestic-ideal-holdings-ltd-rebrands-to-ping-an-biomedical-co-ltd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/majestic-ideal-holdings-ltd-rebrands-to-ping-an-biomedical-co-ltd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PASW","MJID","BK4159"],"gpt_icon":0},{"id":"2570004307","title":"Majestic Ideal Holdings: to Change Name to Ping an Biomedical Co Ltd - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2570004307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570004307?lang=en_us&edition=fundamental","pubTime":"2025-09-26 18:16","pubTimestamp":1758881793,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nFWN3VC1OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4159","MJID","PASW"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}